Manappuram Finance Ltd

- Bain Capital is investing in Manappuram Finance through an 18% capital infusion: 9% equity and 9% convertible warrants into the parent company (Page 5). - The capital raised will be used primarily to support growth in gold loans, secured MSME, and affordable housing lending; subsidiaries' capital needs will be met from this parent infusion as required (Page 5). - The company successfully raised Rs. 2,547 crore in term loans from banks during the quarter, with low CP exposure at 1% (Page 5). - Undrawn bank lines stand at Rs. 2,306 crore and liquidity/cash equivalents at Rs. 3,808 crore (Page 5). - No specific mention of new debt or equity fundraising beyond ongoing Bain Capital infusion and existing term loan facilities; regulatory approvals for Bain transaction are in process (Page 5-6).

- Bain Capital is infusing capital into Manappuram Finance Limited, with an 18% stake via equity (9%) and convertible warrants (9%) coming into the parent company. - The capital infusion is not exclusively for gold loans but primarily targets growth in gold loans, secured MSME lending, and affordable housing. - Capital requirements for subsidiaries will be met from the parent company as per projected growth plans; no fixed amount allocated upfront. - The company aims to focus on secured lending, targeting around 90% of the loan book in secured products. - There is no specific mention of other capex or strategic investments beyond the Bain Capital infusion and growth plans in secured lending segments.

- **Consolidated AUM Growth:** Targeting around 20% growth in FY'26 across gold loans and other segments including vehicle SME and housing portfolios. - **Gold Loan Portfolio:** Expected to grow over 20% in the current financial year, supported by digital onboarding and rural demand. - **Microfinance Portfolio:** Anticipated to decline to about 10% of the consolidated book by year-end due to strategic focus shift. - **Vehicle Finance & MSME:** Growth targeted around 20%, following consolidation and strengthened underwriting. - **Loan Yield & Margins:** Yield expected to moderate due to competitive pressure, but growth and capital leverage will aim to maintain ROE around 18%. - **New Product Adjustments:** Introduction of higher ticket gold loans with competitive pricing to fuel growth despite regulatory changes. - **Bain Capital Infusion:** Will support growth primarily in secured lending including gold, MSME, and affordable housing.

- The company targets consolidated AUM growth of about 20%, with growth expected across gold loans, vehicle finance, MSME, and housing portfolios. - Gold loan AUM is expected to grow robustly over 20% during FY26 despite competition. - Microfinance portfolio is expected to reduce to around 10% of consolidated book by the end of the year. - Profitability: The focus is on improving ROE, with a targeted ROE of around 18% in the next few quarters. - Microfinance losses and provisioning are expected to reduce going forward. - Yield compression expected gradually due to competition but offset by lower borrowing costs and leveraging capital for maintaining ROE. - Bain Capital infusion will help fund growth, mainly for secured lending segments. - Provision coverage remains stable; additional provisioning expected to reduce in coming quarters. - Overall, the company expects steady growth in operating earnings supported by expanding secured loan segments and improved efficiency.

The provided transcript from page 16 of the document does not include any specific information regarding current or expected order book or pending orders for Manappuram Finance Limited. The discussion focuses primarily on loan growth, provisioning, regulatory guidelines, portfolio composition, gold loan pricing, and capital infusion. Therefore, no details on order book or pending orders are available in the provided pages.